In addition, recent studies reported that decreased serum PF4 levels significantly correlated with cognitive decline and CSF levels of β-amyloid (Aβ)42 and t-tau in AD patients [11], and PF4 combined with seven other proteins could benefit early identification of AD patients [17]. The gene discussed is PF4; the disease is Mental deterioration.